Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

VCNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 51.50%

Insider Buying (Last 12 Months): $3,004,638.14

Insider Selling (Last 12 Months): $2,257.92

Vaccinex Insider Trading History Chart

Vaccinex Share Price & Price History

^$4.80

▼ -0.04 (-0.83%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

The only accurate crypto trading system I know …

From Weiss Ratings | Ad

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

Here's what our expert says you should buy before April 14.

Vaccinex Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/26/2023	Strydonck Gerald E. Van	Director	Sell	224	$10.08	$2,257.92
10/3/2023	Albert Friedberg	Director	Buy	214,285	$14.00	$2,999,990.00	339,128
10/3/2023	Maurice Zauderer	CEO	Buy	357	$13.02	$4,648.14	1,222
2/23/2022	Strydonck Gerald E Van	Director	Buy	95	$277.20	$26,334.00
1/27/2022	Jacob B. Frieberg	Director	Buy	429	$233.10	$99,999.90
1/27/2022	Maurice Zauderer	CEO	Buy	8,580	$233.10	$1,999,998.00

The only accurate crypto trading system I know …

From Weiss Ratings | Ad

Here's what our expert says you should buy before April 14.

SEC Filings (Institutional Ownership Changes) for Vaccinex (NASDAQ:VCNX)

50.11% of Vaccinex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vaccinex Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/12/2024	AIGH Capital Management LLC	817,061	$0.54M	0.2%	-25.1%	6.542%
2/9/2024	Worth Venture Partners LLC	654,079	$0.44M	0.2%	-8.8%	5.237%
12/18/2023	Vanguard Group Inc.	48,221	$54K	0.0%	-93.4%	0.386%
11/15/2023	Worth Venture Partners LLC	717,559	$0.81M	0.5%	+417.0%	16.308%
11/15/2023	Armistice Capital LLC	680,000	$0.77M	0.0%	N/A	15.455%
11/13/2023	AIGH Capital Management LLC	1,090,173	$1.23M	0.6%	-19.4%	24.777%
5/16/2023	Susquehanna International Group LLP	99,105	$40K	0.0%	+250.2%	0.181%
5/15/2023	AIGH Capital Management LLC	951,801	$0.38M	0.1%	-61.2%	1.735%
5/1/2023	Virtu Financial LLC	103,898	$42K	0.0%	N/A	0.189%
2/16/2023	AIGH Capital Management LLC	2,451,801	$1.66M	0.5%	+17.8%	4.915%
2/15/2023	Millennium Management LLC	37,964	$25K	0.0%	-46.4%	0.076%
11/15/2022	Citadel Advisors LLC	100,268	$50K	0.0%	+92.1%	0.235%
8/15/2022	Millennium Management LLC	151,666	$0.16M	0.0%	+391.2%	0.355%
5/17/2022	Worth Venture Partners LLC	66,856	$88K	0.0%	N/A	0.157%
5/13/2022	Vanguard Group Inc.	727,265	$0.96M	0.0%	+16.7%	1.705%
5/12/2022	AIGH Capital Management LLC	2,081,801	$2.63M	0.6%	N/A	4.880%
11/16/2021	Telemetry Investments L.L.C.	132,500	$0.29M	0.4%	+10.4%	0.430%
11/15/2021	Natixis	31,895	$69K	0.0%	N/A	0.104%
11/12/2021	Oppenheimer & Co. Inc.	31,751	$69K	0.0%	-24.3%	0.103%
9/17/2021	Virtu Financial LLC	38,026	$0.11M	0.0%	+103.9%	0.123%
8/16/2021	Point72 Asset Management L.P.	395,522	$1.11M	0.0%	N/A	1.390%
8/16/2021	Telemetry Investments L.L.C.	120,000	$0.34M	0.5%	+14.3%	0.422%
8/16/2021	State Street Corp	67,200	$0.19M	0.0%	N/A	0.236%
8/13/2021	Geode Capital Management LLC	104,114	$0.29M	0.0%	+59.4%	0.366%
8/13/2021	Vanguard Group Inc.	600,624	$1.68M	0.0%	+145.9%	2.111%
5/19/2021	Virtu Financial LLC	18,652	$56K	0.0%	N/A	0.066%
5/17/2021	Goldman Sachs Group Inc.	20,447	$61K	0.0%	-41.9%	0.072%
5/13/2021	Bank of New York Mellon Corp	17,954	$54K	0.0%	N/A	0.063%
5/12/2021	Geode Capital Management LLC	65,331	$0.19M	0.0%	N/A	0.230%
5/12/2021	UBS Group AG	28,708	$86K	0.0%	N/A	0.101%
5/10/2021	Oppenheimer & Co. Inc.	42,951	$0.13M	0.0%	-24.3%	0.151%
5/4/2021	Institute for Wealth Management LLC.	20,000	$60K	0.0%	N/A	0.070%
2/17/2021	Tacita Capital Inc	13,574	$28K	0.0%	N/A	0.061%
2/16/2021	Squarepoint Ops LLC	40,583	$84K	0.0%	N/A	0.181%
2/11/2021	Oppenheimer & Co. Inc.	56,751	$0.12M	0.0%	+141.1%	0.254%
12/11/2020	Virtu Financial LLC	26,249	$47K	0.0%	N/A	0.117%
10/20/2020	Wedbush Securities Inc.	31,000	$55K	0.0%	N/A	0.154%
5/18/2020	MSD Partners L.P.	1,161,855	$4.65M	1.3%	-5.2%	7.102%

Data available starting January 2016

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.

Today's Range

Now: $4.80

$4.43

$5.18

50 Day Range

MA: $8.11

$4.76

$12.25

52 Week Range

Now: $4.80

$4.43

$100.80

Volume

11,069 shs

Average Volume

11,855 shs

Market Capitalization

$5.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Who are the company insiders with the largest holdings of Vaccinex?: Vaccinex's top insider investors include:
Albert Friedberg (Director)
Maurice Zauderer (CEO)
Strydonck Gerald E Van (Director)
Learn More about top insider investors at Vaccinex.

Your Money is Not Safe

From American Alternative | Ad

CLICK HERE TO GET YOUR GUIDE NOW